• Thurs news: Merck - Weight-loss drugs and healthcare costs. GSK and Pfizer RSV vaccines in younger adults. Pharma mega-mergers. Lilly launches Mounjaro in Denmark. Lundbeck pipeline. See more on our front page

Merck has new sleep drug coming!









Why should I be?Until Ambien went generic and Marketing didn't know how to niche it anymore,I made bonus checks comparable to Actos bonuses! At least Rozerem didn't kill anyone!!

there was so much potential with a drug that had a unique MOA. A real sales force would have made this a blockbuster. Instead, the 4T reps let this opportunity slip through it's hands and now the whole company suffers. Let's watch and see what Merck can do with their product and realize what Rozerem could be with real effort behind it.
 




there was so much potential with a drug that had a unique MOA. A real sales force would have made this a blockbuster. Instead, the 4T reps let this opportunity slip through it's hands and now the whole company suffers. Let's watch and see what Merck can do with their product and realize what Rozerem could be with real effort behind it.

A "Real Marketing team" would have given us more pertinent selling information AND our MC people would have been better incentivized to get better MC placement instead of majority of bonuses predicated on Actos! Enough blame to go @! Also, besides Actos,what other drug has been launched and marketed successfully!
 




A "Real Marketing team" would have given us more pertinent selling information AND our MC people would have been better incentivized to get better MC placement instead of majority of bonuses predicated on Actos! Enough blame to go @! Also, besides Actos,what other drug has been launched and marketed successfully!

None! Takeda marketing couldn't successfully launch ice cubes in the Sahara desert!